Literature DB >> 12894522

Induction of early apoptosis marker by morphine in human lung and breast carcinoma cell lines.

Ikusuke Hatsukari1, Naoko Hitosugi, Isao Matsumoto, Hiroshi Nagasaka, Hiroshi Sakagami.   

Abstract

We have investigated whether morphine and codeine, potent analgesic compounds most commonly used as cancer pain relievers, show tumor-specific cytotoxic activity and whether they can induce apoptosis or necrosis by monitoring the stainability with Annexin V and propidium iodide with fluorescence-activated cell sorter. Both opioids showed higher cytotoxic activity against three human tumor cell lines (lung carcinoma A549, mammary gland carcinoma MCF7, promyelocytic leukemia HL-60) than against three normal human cells (periodontal ligament fibroblast HPLF, gingival fibroblast HGF, pulp cell HPC). Morphine produced the major part of the apoptotic cell populations and the minor part of the necrotic cell populations in A549 and MCF7 cells, more effectively than codeine. In addition, morphine increased the activity of mitochondrial Mn-containing superoxide dismutase (MnSOD) in HL-60 cells, but decreased the MnSOD activity in A549 and MCF7 cells. The apoptosis-inducing activity of opioids may provide new strategies for the treatment and prevention of cancer.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12894522

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  3 in total

Review 1.  Morphine as a treatment of cancer-induced pain-is it safe? A review of in vivo studies and mechanisms.

Authors:  David Brinkman; Jiang H Wang; Henry P Redmond
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-09-20       Impact factor: 3.000

Review 2.  Can regional anesthesia and analgesia prolong cancer survival after orthopaedic oncologic surgery?

Authors:  Juan P Cata; Mike Hernandez; Valerae O Lewis; Andrea Kurz
Journal:  Clin Orthop Relat Res       Date:  2014-05       Impact factor: 4.176

Review 3.  The role of morphine in regulation of cancer cell growth.

Authors:  Katarzyna Gach; Anna Wyrębska; Jakub Fichna; Anna Janecka
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-07-29       Impact factor: 3.000

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.